News on Leukemia_Myeloid_Chronic from BioPortfolio.com http://www.BioPortfolio.com Consolidated Leukemia_Myeloid_Chronic news from BioPortfolio.com Wed, 10 Feb 2010 10:19:38 GMT en ChemGenex May Face Panel Queries About Omapro Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039491&HITNO=0&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039491&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039491&HITNO=0&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039491&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=1&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=1&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=2&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=2&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: Limited Benefit Seen in CML Drug, FDA Sayshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036549&HITNO=3&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036549&THISHREF=http://c.moreover.com/click/here.pl%3fz2536654782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036549&HITNO=3&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036549&THISHREF=http://c.moreover.com/click/here.pl%3fz2536654782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedPage Today: CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omaprohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032431&HITNO=4&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032431&THISHREF=http://c.moreover.com/click/here.pl%3fz2534648662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032431&HITNO=4&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032431&THISHREF=http://c.moreover.com/click/here.pl%3fz2534648662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMorningstar.com: CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omaprohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032402&HITNO=5&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032402&THISHREF=http://c.moreover.com/click/here.pl%3fz2534639444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032402&HITNO=5&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032402&THISHREF=http://c.moreover.com/click/here.pl%3fz2534639444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXNews.com: CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omaprohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032380&HITNO=6&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032380&THISHREF=http://c.moreover.com/click/here.pl%3fz2534635716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032380&HITNO=6&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032380&THISHREF=http://c.moreover.com/click/here.pl%3fz2534635716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omaprohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032334&HITNO=7&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032334&THISHREF=http://c.moreover.com/click/here.pl%3fz2534606823%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032334&HITNO=7&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032334&THISHREF=http://c.moreover.com/click/here.pl%3fz2534606823%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLloyd's: CORRECT: FDA: Low Response Rate Seen With Proposed Drug Omaprohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032302&HITNO=8&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032302&THISHREF=http://c.moreover.com/click/here.pl%3fz2534592461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032302&HITNO=8&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032302&THISHREF=http://c.moreover.com/click/here.pl%3fz2534592461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedulehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038207&HITNO=9&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038207&THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038207&HITNO=9&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038207&THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedulehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037862&HITNO=10&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037862&THISHREF=http://c.moreover.com/click/here.pl%3fz2537335541%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037862&HITNO=10&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037862&THISHREF=http://c.moreover.com/click/here.pl%3fz2537335541%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Extreme Weather In Washington D.C. Has Postponed The FDA's Oncologic Drugs Advisory Committee Meeting Schedulehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037776&HITNO=11&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037776&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037776&HITNO=11&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037776&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Extreme Weather in Washington D.C. has Postponed the FDA s Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033557&HITNO=12&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033557&THISHREF=http://c.moreover.com/click/here.pl%3fz2535267195%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033557&HITNO=12&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033557&THISHREF=http://c.moreover.com/click/here.pl%3fz2535267195%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033042&HITNO=13&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033042&THISHREF=http://c.moreover.com/click/here.pl%3fz2534957334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033042&HITNO=13&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033042&THISHREF=http://c.moreover.com/click/here.pl%3fz2534957334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Extreme Weather in Washington D.C. has Postponed the FDAs Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032811&HITNO=14&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032811&THISHREF=http://c.moreover.com/click/here.pl%3fz2534825744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032811&HITNO=14&MSIZE=712&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Leukemia_Myeloid_Chronic&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032811&THISHREF=http://c.moreover.com/click/here.pl%3fz2534825744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCentre Daily Times: